What is the Current Share Price of Balaxi Pharmaceuticals Ltd?
- Answer Field
-
Balaxi Pharmaceuticals Ltd share price is for NSE ₹ 26.21 & for BSE ₹ 0.00 as on May 29 2026 03:28 PM.
As of the latest trading session, BALAXI PHARMA LTD is trading at ₹26.21, up by ₹1.24 or 4.96% from its previous close. The stock has moved between ₹24.95 and ₹26.21 today. Over the past year, the stock has delivered a return of -51.96%. In the last month, it has returned -6.16%.
| Particulars | DEC 2025 (Values in Cr) |
|---|---|
| Revenue | 24.59 |
| Operating Expense | 24.09 |
| Net Profit | 1.53 |
| Net Profit Margin (%) | 6.22 |
| Earnings Per Share (EPS) | 0.28 |
| EBITDA | 3.00 |
| Effective Tax Rate (%) | 27.83 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 34.88 | 14.41 | 1.68 | 267.30 | 23.12 | 40.00 |
| BLISS GVS PHARMA LTD. | 396.35 | 32.07 | 3.51 | 4192.95 | 118.35 | 399.00 |
| CIPLA LTD | 1418.20 | 28.08 | 3.32 | 114562.27 | 1165.55 | 1672.20 |
| FERMENTA BIOTECH LIMITED | 293.20 | 12.93 | 2.12 | 862.92 | 256.40 | 399.00 |
| Company Name | Price | P/E | P/B | Market Cap | 52 Week Low | 52 Week High |
|---|---|---|---|---|---|---|
| AMBALAL SARABHAI ENT L | 34.88 | 24.39 | 4.49 | 267.30 | 23.12 | 40.00 |
| AMRUTANJAN HEALTH CARE LTD. | 559.20 | 25.06 | 4.36 | 1616.68 | 490.00 | 789.95 |
| ASTRAZENECA PHARMA IND LT | 8655.30 | 104.02 | 27.08 | 21638.25 | 7630.00 | 10653.05 |
| BLISS GVS PHARMA LTD. | 396.35 | 42.62 | 3.62 | 4192.95 | 118.35 | 399.00 |
Choose a Plan That Suits Your Goals and Needs
Freedom Pack
Subscription Charge : FREE
Professional Pack
Subscription Fee : ₹2,500 Yearly
Signature
Account Opening : FREE
*Note: The Freedom Pack is free for the first year and has an annual fee of ₹431 from the second year onwards.
Balaxi Pharmaceuticals has shown a mixed performance for the quarter ending June 2024. Despite a slight decline in net sales, which dipped by 0.51% year-over-year to Rs 65.62 crore, the company achieved a significant increase in net profit. The net profit soared by 115.67%, reaching Rs 6.48 crore compared to Rs 3.01 crore in the same period last year. Read More... The EBITDA also saw a modest rise of 5.1%, standing at Rs 8.24 crore. This strong profitability, despite flat sales, may positively influence the Balaxi Pharma share price. Investors are likely to view this as a sign of improved operational efficiency and profitability, which could drive future growth. Read Less
The annual report of Balaxi Pharmaceuticals offers a detailed overview of the company's financial and operational performance over the past fiscal year. It provides insights into revenue streams, cost management, and profitability, which are crucial for understanding the company's overall health and growth prospects. For those tracking the Balaxi Pharma share price, Read More...the annual report is an essential document that sheds light on the company's strategic direction, market positioning, and potential for future growth. It also includes information on the company’s governance practices and sustainability initiatives, providing a comprehensive picture of its operations. Read Less
Balaxi Pharmaceuticals' dividend policy is a key point of interest for investors, particularly given the company's strong net profit growth in the recent quarter. While net sales remained relatively flat, the significant increase in profitability could result in favorable dividend payouts. The Balaxi Pharma share price could be positively impacted by a strong dividend announcement, signaling the company’s commitment to returning value to its shareholders. Investors will be looking closely at the upcoming dividend declaration to gauge the company’s financial stability and its approach to balancing growth with shareholder returns.
Balaxi Pharmaceuticals Ltd share price is for NSE ₹ 26.21 & for BSE ₹ 0.00 as on May 29 2026 03:28 PM.
The market cap of Balaxi Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on May 29 2026 03:28 PM.
The 52 Week High and Low of Balaxi Pharmaceuticals Ltd for NSE is ₹ 63.90 and ₹ 15.20 and for BSE is ₹ 0.00 and ₹ 0.00.
The 1 year returns on the stock has been -51.96%.
As on May 29 2026 03:28 PM the price-to-earnings (PE) ratio for Balaxi Pharmaceuticals Ltd share is 36.19.
As on May 29 2026 03:28 PM, the price-to-book (PB) ratio for Balaxi Pharmaceuticals Ltd share is 23.78.
You can trade in Balaxi Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.
To buy Balaxi Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Balaxi Pharmaceuticals Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found